Our research department at Suncoast Skin Solutions in Florida conducts dermatology clinical trials for new investigational products and innovative medical devices for various dermatology conditions. Led by our Lead Principal Investigators, Dr. Christopher Ewanowski and Dr. Pearl C. Kwong, MD, PhD, we are dedicated to utilizing and advancing the best available therapies in Dermatology. With over 30 years of combined clinical research experience, our research staff consists of a Principal Investigator, various Sub-Investigators, trained Clinical Research Coordinators, Regulatory Personnel, and other important research ancillary support staff. Whether you choose to participate in a dermatology clinical trial in Florida, or seek medicine and treatments from any of our bright and knowledgeable providers, we are here to help!
Current Clinical Studies
Types of Dermatology Clinical Trials at our FL Locations
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical
research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
FAQ’s
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical
research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Dermatological Drugs
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical
research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Melanoma Drugs
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical
research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.Also known as exploratory trials or microdosing studies, Phase 0 trials are the earliest phase of dermatology clinical research. At our Florida clinics, the trials involve a small number of participants (usually fewer than 15) and administer a sub-therapeutic dose of the investigational drug or treatment. The main objective is to gather initial information on how the drug behaves in the human body, including its absorption, distribution, metabolism, and excretion.
Interested in participating?
Are you a Sponsor and would like to work with us?
Why choose Apex clinical trials?
15 years of solid dermatology clinical research expertise at Florida’s Suncoast Skin Solutions with almost 70 providers and 30 offices and over 20,000 patient visits a month mean that your trials have plentiful patients to fill a study regardless of disease state.
Experiences with many trials of all sizes and phases has created a team that’s agreeable, competent, and accessible. This team has had NO turnover. The staff and investigators have remained steady.
We stand ready to give a tour, fill in a rescue site, or start from the beginning with you. We have 5 approved sites throughout Florida, to make patient visits close and easy.
Please contact our Lead Clinical Research Coordinator to schedule a meeting or call:
Lisa Thomas
[email protected]
(904) 755-1374
